Cargando…
Timely and individualized heart failure management: need for implementation into the new guidelines
Due to remarkable improvements in heart failure (HF) management over the last 30 years, a significant reduction in mortality and hospitalization rates in HF patients with reduced ejection fraction (HFrEF) has been observed. Currently, the optimization of guideline-directed chronic HF therapy remains...
Autores principales: | Abdin, Amr, Bauersachs, Johann, Frey, Norbert, Kindermann, Ingrid, Link, Andreas, Marx, Nikolaus, Lainscak, Mitja, Slawik, Jonathan, Werner, Christian, Wintrich, Jan, Böhm, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117452/ https://www.ncbi.nlm.nih.gov/pubmed/33983472 http://dx.doi.org/10.1007/s00392-021-01867-2 |
Ejemplares similares
-
‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor
por: Abdin, Amr, et al.
Publicado: (2021) -
Optimization of Heart Failure Treatment by Heart Rate Reduction
por: Böhm, Michael, et al.
Publicado: (2019) -
A practical approach to the guideline‐directed pharmacological treatment of heart failure with reduced ejection fraction
por: Abdin, Amr, et al.
Publicado: (2022) -
Management strategies in heart failure with preserved ejection fraction
por: Wintrich, Jan, et al.
Publicado: (2022) -
Sacubitril/valsartan in heart failure: efficacy and safety in and outside clinical trials
por: Abdin, Amr, et al.
Publicado: (2022)